老年人心血管疾病合并神经精神疾病多重用药风险防控专家共识

Expert consensus on risk prevention and control of multiple drug use in elderly patients with cardiovascular diseases and neuropsychiatric diseases

老年人多重用药非常普遍,其会明显增加药物相互作用和不良反应。心血管疾病合并神经精神疾病是老年人最为常见的多病共患,也是涉及多重用药最多的疾病组合之一。中华医学会临床药学分会组织相关专家,针对心血管疾病合并神经精神疾病的老年患者,利用国外用药风险评估工具,结合相关循证结果,制定了我国《老年人心血管疾病合并神经精神疾病多重用药风险防控专家共识》,进一步推广应用于临床疾病治疗实践,以减少我国老年人的不良临床结局。

Multiple drug use is very common in the elderly,which will significantly increase drug interactions and adverse drug reactions.Cardiovascular disease complicated with neuropsychiatric disease is the most common multi-disease comorbidity among the elderly,and it is also one of the disease combinations involving the most multiple drug use.In order to reduce the adverse clinical outcomes of the elderly in China,Chinese Society of Clinical Pharmacy of Chinese Medical Association organized relevant experts to develop Expert Consensus on Risk Prevention and Control of Multiple Drug Use in Elderly Patients with Cardiovascular Diseases and Neuropsychiatric Diseases in China by using foreign drug use risk assessment tools and combining relevant evidence-based results,and further promote its application in clinical disease treatment practice to reduce the adverse clinical outcomes of the elderly in China.